Zobrazeno 1 - 10
of 89
pro vyhledávání: '"35"'
Publikováno v:
Contraception. 76:8-17
Purpose This study compared two oral contraceptives (OCs) with the same triphasic regimen of progestin (norgestimate 0.18, 0.215 and 0.25 mg) but differing doses of ethinyl estradiol (EE) — 25 and 35 µg EE — in their effects on androgens, mood a
Publikováno v:
Contraception. 73:223-228
Context There is concern that a new transdermal contraceptive patch containing ethinyl estradiol (EE) and the progestin norelgestromin increases the risk for venous thromboembolism (VTE) compared to previously marketed oral contraceptives (OCs). Obje
Autor:
Tânia Regina Leme Martinez, José Mendes Aldrighi, Geraldo Rodrigues de Lima, Luis Bahamondes, Carlos Alberto Petta, Maria Eugenia Caetano
Publikováno v:
Contraception. 69:395-399
Twenty-nine women aged 35 years old or more, using triphasic combined oral contraceptive (COC) were evaluated during six cycles for the following parameters: total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cho
Autor:
Anthony DelConte, Bruce R. Carr
Publikováno v:
Contraception. 65:397-402
The efficacy, safety, and cycle control of a low-dose oral contraceptive (OC) containing 20 microg ethinyl estradiol (EE) and 100 microg levonorgestrel (LNG) has been demonstrated in a large trial with 1708 women (or=15 years old with regular menstru
Autor:
Anibal Faundes, Pablo Pecci, Luis Bahamondes, Silvio Matera, Bruno Sobreira-Lima, Jeffrey F. Lui-Filho
Publikováno v:
Contraception. 72:337-341
Objective The objective of the study was to evaluate the performance of the TCu 380A IUD in women who had been using the device for more than 10 years and who were 35 years of age or more on completion of the 10th year of IUD use. Methods A total of
Autor:
E. Mugnier, J.B. Dubuisson
Publikováno v:
Contraception. 66:121-128
This open, noncomparative study evaluated the rate of premature removals of the levonorgestrel-releasing intrauterine system (LNG-IUS) Mirena because of adverse events. To take part in the study, women had to be aged between 35 years and 45 years, an
Publikováno v:
Contraception. 59:17-23
The interaction between smoking and oral contraceptive (OC) use with respect to thrombogenesis was investigated by studying the effects of OC and smoking on urinary prostacyclin (PGI 2 ) and thromboxane A 2 (TxA 2 ) metabolite levels in smokers and n
Publikováno v:
Contraception. 69:489-491
A prospective study of Implanon implant use in women older than 35 was conducted in Bangkok, Thailand. The purposes of this study were to evaluate the menstrual pattern and side effects of Implanon in 51 women followed for 6 months. Their mean age wa
Autor:
A. Covelli, Chiara Benedetto, G. Fanizza, M. Mauloni, G. F. Trossarelli, Domenico De Aloysio, Gianluca Gennarelli
Publikováno v:
Contraception. 51:13-18
In a multicenter prospective trial, 58 healthy women aged between 35 and 49 years were studied for one year (639 cycles) while taking an oral contraceptive (OC) containing desogestrel 0.150 mg and ethinylestradiol (EE) 0.020 mg. Efficacy, control of
Publikováno v:
Contraception. 61:281-282
A prospective study of depot-medroxyprogesterone acetate (DMPA) use in women aged above 35 years was conducted in Bangkok, Thailand. The objectives of the study were to evaluate efficacy, continuation rate, and side effects of DMPA use in these women